Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	52.38	145.31	54.94	61.74	207.34	191.92
Short-Term Investments	117.8	33.8	112.95	151.68	-	-
Cash & Short-Term Investments	170.18	179.1	167.89	213.42	207.34	191.92
Cash Growth	58.64%	6.68%	-21.33%	2.93%	8.03%	-6.45%
Accounts Receivable	60.03	41.77	41.53	35.41	20.96	18.08
Other Receivables	-	6.67	8.64	7.21	4.37	9.52
Receivables	60.03	48.44	50.17	42.62	25.33	27.59
Inventory	64.58	64.9	55.72	56.76	42.33	27.31
Prepaid Expenses	-	6.26	4.65	3.54	2.29	2.39
Restricted Cash	0.73	0.76	-	-	0.21	0.23
Other Current Assets	-	0	-	-	-	-
Total Current Assets	295.51	299.47	278.44	316.34	277.5	249.44
Property, Plant & Equipment	23.1	23.97	24.13	33.47	39.15	33.17
Long-Term Investments	8.11	8.65	4.23	10.4	9.73	8.65
Goodwill	-	3.32	-	-	-	-
Other Intangible Assets	130.99	132.22	61.04	71.27	74.87	83.57
Long-Term Deferred Tax Assets	30.67	31.02	30.54	29.76	22.97	21.22
Long-Term Deferred Charges	-	-	-	-	0.25	0.27
Other Long-Term Assets	0.99	1.32	1.6	1.62	1.33	1.01
Total Assets	489.37	499.96	399.99	462.85	425.8	397.32
Accounts Payable	103.53	8.55	10.1	16.02	8.75	7.6
Accrued Expenses	-	91.31	53.22	50.27	43.61	33.34
Current Portion of Long-Term Debt	5.38	5.34	4.25	1.82	1.77	1.88
Current Portion of Leases	2.77	3.37	2.95	3.62	3.47	2.42
Current Income Taxes Payable	-	6.04	3.28	6.23	2.1	1.51
Other Current Liabilities	0.68	1.19	-	-	-	0.03
Total Current Liabilities	112.35	115.79	73.8	77.97	59.7	46.77
Long-Term Debt	93.39	92.72	78.15	136.6	131.62	139.01
Long-Term Leases	14.67	14.35	26.97	29.51	29.84	18.46
Other Long-Term Liabilities	-0	-	-	-	-	0.17
Total Liabilities	220.41	222.86	178.92	244.07	221.16	204.4
Common Stock	8.07	8.01	7.77	7.67	7.51	7.43
Additional Paid-In Capital	518.6	513.26	488.99	478.43	462.3	455.25
Retained Earnings	-281.46	-258	-287.92	-265.5	-265.17	-269.77
Comprehensive Income & Other	23.75	13.84	12.23	-1.82	-	-
Shareholders' Equity	268.96	277.1	221.06	218.78	204.64	192.92
Total Liabilities & Equity	489.37	499.96	399.99	462.85	425.8	397.32
Total Debt	116.21	115.78	112.31	171.55	166.69	161.76
Net Cash (Debt)	53.97	63.33	55.58	41.88	40.65	30.16
Net Cash Growth	-	13.94%	32.72%	3.03%	34.76%	-30.18%
Net Cash Per Share	0.07	0.08	0.08	0.06	0.06	0.04
Filing Date Shares Outstanding	744.71	701.68	683.93	673.44	656.35	648.75
Total Common Shares Outstanding	744.71	701.68	680.31	671.07	656.35	648.75
Working Capital	183.17	183.68	204.64	238.37	217.8	202.67
Book Value Per Share	0.36	0.39	0.32	0.33	0.31	0.30
Tangible Book Value	137.97	141.56	160.02	147.51	129.77	109.35
Tangible Book Value Per Share	0.19	0.20	0.24	0.22	0.20	0.17
Land	-	-	-	-	-	0.03
Machinery	-	10.57	9.3	9.66	8.28	14.84
Construction In Progress	-	-	0.15	0.18	0.01	0.62
Leasehold Improvements	-	6.4	5.43	5.55	5.28	5.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.